EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage Glioma

Siyu Chi, Li Zhang, Hemei Cheng, Yaran Chang, Yaoyao Zhao, Xiayan Wang, Zhihong Liu iD

Angewandte Chemie International Edition · 17.07.2023 · 62 (29)

DOI: 10.1002/anie.202304419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 12.06.2023. Verfasst von Siyu Chi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Sciences, Wuhan University, 430072, Wuhan, P. R. China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Nanoparticles, Nanocomposites. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Outstanding Youth Science Fund Project of National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma features high fatality rate and short survival time of patients due to its fast growth speed and high invasiveness, hence timely treatment of early‐stage glioma is extremely important. However, the blood brain barrier (BBB) severely prevents therapeutic agents from entering the brain; meanwhile, the non‐targeted distribution of agents always causes side effects to vulnerable cerebral tissues. Therefore, delivery systems that possess both BBB penetrability and precise glioma targeting ability are keenly desired. We herein proposed a hybrid cell membrane (HM) camouflage strategy to construct therapeutic nanocomposites, in which HM consisting of brain metastatic breast cancer cell membrane and glioma cell membrane was prepared with a simple membrane fusion pathway. By coating HM onto drug‐loaded nanoparticles, the as‐obtained biomimetic therapeutic agent (termed HMGINPs) inherited satisfying BBB penetrability and homologous glioma targeting ability simultaneously from the two source cells. HMGINPs exhibited good biocompatibility and superior therapeutic efficacy towards early‐stage glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsNanoparticlesNanocompositesHumansBiomimeticsCell Line, TumorBlood-Brain BarrierCell MembraneDrug Delivery Systems

Stichwörter der Autor:innen

Biomimetic NanocompositesBlood-Brain BarrierGlioma InhibitionHomologous TargetingHybrid Cell Membranes

Autor:innen und Institutionen

  • College of Chemistry and Molecular Sciences, Wuhan University, 430072, Wuhan, P. R. China.
  • College of Health Science and Engineering, Hubei University, 430062, Wuhan, P. R. China.
  • Center of Excellence for Environmental Safety and Biological Effect, Department of Chemistry, Beijing University of Technology, 100124, Beijing, P. R. China.

ORCID-Profile: Zhihong Liu

Förderung

  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Chi, S., Zhang, L., Cheng, H., Chang, Y., Zhao, Y., Wang, X., & Liu, Z. (2023). Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage Glioma. Angewandte Chemie International Edition, 62(29). https://doi.org/10.1002/anie.202304419

Vancouver

Chi S, Zhang L, Cheng H, Chang Y, Zhao Y, Wang X, et al. Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage Glioma. Angewandte Chemie International Edition. 2023;62(29). doi:10.1002/anie.202304419

BibTeX
@article{Chi2023,
  author = {Chi, Siyu and Zhang, Li and Cheng, Hemei and Chang, Yaran and Zhao, Yaoyao and Wang, Xiayan and Liu, Zhihong},
  title = {Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage Glioma},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  volume = {62},
  number = {29},
  doi = {10.1002/anie.202304419}
}
Kostenlos starten →